Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Neo Cremar Co., Ltd. (311390:KRX), powered by AI.
Neo Cremar Co., Ltd. is currently trading at ₩4,370. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Neo Cremar Co., Ltd. on Alpha Lenz.
Neo Cremar Co., Ltd.'s P/E ratio is 18.5.
“Neo Cremar Co., Ltd. trades at a P/E of 18.5 (fair value) with modest ROE of 4.1%. 3Y revenue CAGR of 45.3% highlights clear growth momentum.”
Ask for details →Neo Cremar Co., Ltd. is an innovative biochemical company specializing in the development and production of functional food ingredients and biopolymers. The company's primary function is to manufacture products that enhance the nutritional value and functional properties of food and beverage offerings. Notable features of Neo Cremar's product lines include probiotics, prebiotics, and various natural extracts that serve the diverse needs of the nutrition, cosmetics, and pharmaceutical sectors. In the financial market, Neo Cremar Co., Ltd. plays a significant role by supplying essential bio-ingredients that support the global trend towards healthier eating habits and natural products. Its contributions are crucial for manufacturers aiming to align with consumer demand for wellness-enhancing food products. The company’s focus on research and development underscores its commitment to innovation, positioning it as a key player in the biochemistry and functional foods industries. Through strategic partnerships and a robust distribution network, Neo Cremar is an important entity in both domestic and international markets, helping shape modern dietary trends and contributing to advancements in health-related product offerings.
“Neo Cremar Co., Ltd. trades at a P/E of 18.5 (fair value) with modest ROE of 4.1%. 3Y revenue CAGR of 45.3% highlights clear growth momentum.”
Ask for details →Neo Cremar Co., Ltd. (ticker: 311390) is a company listed on KRX in the Basic Materials sector (Specialty Chemicals). It has approximately 66 employees. Market cap is $55.3B.
The current price is ₩4,370 with a P/E ratio of 18.54x and P/B of 0.75x.
ROE is 4.13% and operating margin is 6.60%. Annual revenue is $81.9B.